DDrare: Database of Drug Development for Rare Diseases

Zn (DrugBank: -)

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	1
299	嚢胞性線維症	2

113. 筋ジストロフィー　［臨床試験数：567，薬物数：442（DrugBank：93），標的遺伝子数：55，標的パスウェイ数：151］

Searched query = "Muscular dystrophy", "Dystrophinopathies", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "Rigid spine syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 567 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01596803 (ClinicalTrials.gov)	May 1, 2010	5/4/2012	Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)	Effects of Antioxidants Supplementation on Muscular Function of Patients Affected by Facioscapulohumeral Dystrophy (FSHD)	Facioscapulohumeral Muscular Dystrophy	Procedure: Taking of blood;Dietary Supplement: needle biopsy of the vastus lateralis muscle;Dietary Supplement: Vit C Vit E Zn Se;Dietary Supplement: Placebo Vit E Placebo Vit C Zn Se	University Hospital, Montpellier	Hospital Clinical Research Project 2010;Association Amis FSH France;FSH Dutch Fondation The Netherland	Completed	18 Years	60 Years	All	54	N/A	France

299. 嚢胞性線維症　［臨床試験数：1,592，薬物数：1,539（DrugBank：255），標的遺伝子数：81，標的パスウェイ数：162］

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

2 / 1,592 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04302428 (ClinicalTrials.gov)	August 29, 2019	6/3/2020	Zinc Status and Growth in Cystic Fibrosis	Zinc Status and Growth in Cystic Fibrosis	Cystic;Fibrosis	Biological: Serum Zn;Biological: Red Blood Cell Zn	Indiana University	NULL	Recruiting	3 Months	3 Years	All	38		United States
2	NCT00221559 (ClinicalTrials.gov)	September 2004	12/9/2005	Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group	Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group	Cystic Fibrosis	Procedure: Blood sampling for determination of serum Zn	University Hospital, Ghent	Scientific research fund Bruges	Completed	N/A	N/A	Both	0	N/A	Belgium